Breaking News

Connect the Dots to Catch Roadside Bombers
03/15/2011 By tony Leave a Comment
A while back, my attention was captured by a National Public Radio piece describing how the US Military is applying Social Network Analysis tools and methods to catch roadside bombers in Iraq and Afghanistan. While some on our team were surprised, Social Network Analysis can trace a direct history to the “link analysis” methods that… more »

The Most Valuable KOLs in Your Network
03/14/2011 By Philip Leave a Comment
Rob Cross recently posted a clear insightful view about “The Most Valuable People in Your Network.” In regards to building social capital, he illustrates the difference between quality and quantity. I won’t repeat the article here, but it goes without saying that the same approach applies to Key Opinion Leaders. At Lnx we often see… more »
Key Opinion Leaders
Market Access is a Changing – Map Stakeholders to Understand Payor Policies
Writing an article about market forces and issues facing the Pharmaceutical industry is easy. But Mark Halliday in his recent article "Success Factors for Market Access in the Pharmaceutical Industry" has put together a collection of ideas to to improve market access. Mark talks about the need to recognize the market has fragmented, and then carefully map the stakeholders to create targeted messages that address their needs. Lnx Pharma would agree that mapping is essential to understanding. The increasing use of HTAs, health technology assessments, by healthcare payor organizations (mainly governments and insurance companies) makes it crucial to understand who is connected to whom. … »Tell me more!
Learning Social Network Analysis

Learning social network analysis
Phillip Bonacich at Sunbelt Conference 2009 Image by Marc_Smith via Flickr After 200 peer review papers and countless other readings, I can safely say I've scratched the surface of social network analysis. For a 40-year-old science, it can still feel like a new challenge daily, and I'm often asked where to start in terms of learning the ropes. For a brief overview consider the LnxPharma Social Network Analysis Primer. I'd highly recommend you start with Bob Hanneman's online Introduction to social network methods. Professor Hanneman's manual focuses on using UCINET, which is a good all-around social network analysis program but for small data sets. If you need large data sets, use Valdo Batagelj's PAJEK software. You can also join INSNA - International Network for Social Network Analysis and attend SUNBELT, their annual international congress. Steve Wasserman's Social Network Analysis (1994) is a classic and must read. For an updated overview read David … »Tell me more!
Overheard in the Lab

Lnx Pharma Helps Cure HIV
Image via Wikipedia It’s the year 2020, and HIV no longer exists; an effective vaccine has been discovered. Ok, it's unpredictable, but the dream may be closer to reality than you think. Picture this in the very near future: we’re in a remote village in Africa, there is a line of people waiting to receive HIV vaccine, improving their lives forever by eradicating the disease that has killed millions in their country. Doctor Santiago Moreno-Guillén of Spain, along with a few other colleagues, is present in the room. However, they are not the only ones who bear witness to this historical event. You see with the help of a small webcam connected to his laptop, the event is being broadcasted to colleagues Julio Montaner in Canada , and Bernard Hirschel in Switzerland and live to the world on the internet. Dr. Moreno-Guillén answers viewer questions from around the globe. How did we get to this rosy future in only 10 short years? Our hero Dr. Moreno-Guillén would tell you … »Tell me more!
Social Network Analysis
Andrew Witty, CEO of GlaxoSmithKline: How to do more with less and still be innovative
12/02/2010 By Philip Leave a Comment
In his one page opinion piece in The Economist, GlaxoSmithKline CEO Andre Witty gives his view on … »
White Papers

Lnx Pharma Helps Cure HIV
Image via Wikipedia It’s the year 2020, and HIV no longer exists; an effective vaccine has … »